基于SE-EPI的T2 mapping用于前列腺癌表征的验证:与传统CPMG方法的对比研究
回顾性纳入42例前列腺癌患者和42例非癌患者,在活检前行3.0T MRI(b值0–2000 s/mm²,TE 32–100 ms),比较SE-EPI与CPMG两种T2 mapping方法的一致性及相关性。两种方法测量结果呈高度一致,CPMG-T2与SE-EPI-T2平均相关性为中度正相关,非癌组在b=200 s/mm²时相关性最佳(r=0.557,P=0.000),癌组在b=100 s/mm²时最佳(r=0.537,P=0.000)。癌与非癌组间T2值及ADC值差异均有统计学意义(P=0.000)。作者认为SE-EPI-T2 mapping具有前列腺临床应用潜力,可考虑作为传统CPMG-T2 mapping的替代方法。
要点
- SE-EPI与CPMG两种T2 mapping方法测量结果呈高度一致,支持SE-EPI作为替代方案。
- 癌与非癌组间T2值及ADC值差异均有统计学意义(P=0.000)。
- CPMG-T2与SE-EPI-T2相关性为中度正相关,癌组最佳在b=100 s/mm²,非癌组最佳在b=200 s/mm²。
核心结论
- SE-EPI法与CPMG法测量结果呈高度一致,基于SE-EPI的T2 mapping对前列腺具有潜在临床价值,可考虑作为传统CPMG-T2 mapping方法的替代。
研究设计与样本
- 回顾性研究,纳入42例前列腺癌患者和42例非癌患者,活检前行3.0T MRI,b值范围0–2000 s/mm²,TE范围32–100 ms。
诊断标准与关键数值
- 采用Bland-Altman分析评价两种方法的一致性;CPMG-T2与不同b值下SE-EPI-T2的相关性用Spearman rho或Pearson分析;癌与非癌组间差异用Mann-Whitney U检验和两样本t检验。非癌组CPMG-T2与SE-EPI-T2最佳相关性见于b=200 s/mm²(r=0.557,P=0.000),癌组最佳相关性见于b=100 s/mm²(r=0.537,P=0.000)。
临床应用与阅片要点
- 作者认为基于SE-EPI的T2 mapping具有前列腺临床应用潜力,可考虑作为传统CPMG-T2 mapping方法的替代。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We aim to compare the results of spin echo-echo planar imaging (SE-EPI)-based T2 mapping with those of the conventional Carr-Purcell-Meiboom-Gill (CPMG) method and to investigate the potential validity of SE-EPI-T2 mapping for the characterization of prostate cancer (PCa).
METHODS: Our retrospective study included 42 PCa patients and 42 noncancer patients who underwent 3.0T MRI with b values ranging from 0 to 2000 s/mm2 and echo times (TEs) ranging from 32 to 100 ms before biopsies. Bland-Altman analysis was used to compare the agreement between the two methods. The correlations between CPMG-T2 values and SE-EPI-T2 values at different b values were determined by Spearman's rho analysis or Pearson analysis. The Mann-Whitney U test and two-sample t tests were used to analyze the differences between the cancerous and noncancerous groups.
RESULTS: Substantial agreement regarding the measurements was observed between the two methods. The average correlation between the CPMG-T2 values and SE-EPI-T2 values was moderate and positive, and the best correlations were found at b = 200 s/mm2 in the noncancer group (r = 0.557, P = 0.000) and at b = 100 s/mm2 in the cancer group (r = 0.537, P = 0.000). In addition, statistically significant differences were found between the noncancer and cancer groups in T2 values and ADC values (diff TEs) (P = 0.000).
CONCLUSIONS: Substantial agreement in the measurements was found between the SE-EPI method and CPMG method. SE-EPI-based T2 mapping has potential clinical value for the prostate and can be considered an alternative to the traditional CPMG-T2 mapping method.
引用
- Ke Z, Yan X, Min X, et al. Validation of SE-EPI-based T2 mapping for characterization of prostate cancer: a new method compared with the traditional CPMG method. Abdom Radiol (NY). 2019. PMID: 31218387. doi:10.1007/s00261-019-02105-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。